In the footsteps of AstraZeneca, Novartis commits to carbon-neutral supply chain by 2030
Following in AstraZeneca’s carbon-reduced footsteps, Novartis announced new sustainability targets on Tuesday, which include plans to neutralize supply chain emissions in the next 10 years.
The Swiss pharma aims to be carbon-neutral in its own operations by 2025, and across its supply chain by 2030. To get there, it says it will reduce absolute emissions by 35% across its value chain, and follow a “dual strategy” to decrease energy and fuel consumption, improve efficiency and adopt renewable energy sources. It audited all major sites for potential improvements.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters